Athyrium Capital Management’s CareMax, Inc. Class A Common Stock CMAX Stock Holding History

Athyrium Capital Management’s Portfolio CMAX Stock Details CMAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-148,907	Closed	-$16.3M	–	10
2022 Q4	$16.3M	Hold	148,907	–	–	6.85%	6
2022 Q3	$31.7M	Sell	148,907 -667	-0.4%	-$135K	11.86%	3
2022 Q2	$16.3M	Hold	149,574	–	–	6.85%	6
2022 Q1	$33.5M	Hold	149,574	–	–	11.92%	4
2021 Q4	$34.5M	Hold	149,574	–	–	12.29%	4
2021 Q3	$43.3M	Buy	149,574 +20,355	+16%	+$5.99M	27.5%	3
2021 Q2	$50M	Buy	+129,219	New	+$51.3M	20.85%	3

Other funds holding CMAX

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Athyrium Capital Management's CMAX Position: Q1 2023 in Review

Athyrium Capital Management sold out of CareMax, Inc. Class A Common Stock (CMAX) in Q1 2023, closing a stake of 148,907 shares — an estimated $16.3M sold.

Athyrium Capital Management first reported a position in CMAX in Q2 2021 and held it in 7 quarters. The position peaked at $50M in Q2 2021. 86 funds tracked by Wall St. Rank hold CMAX as of Q1 2023.

Athyrium Capital Management reported no remaining CareMax, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Athyrium Capital Management sold 148,907 CareMax, Inc. Class A Common Stock shares in Q1 2023, an estimated $16.3M.
Athyrium Capital Management first reported a position in CareMax, Inc. Class A Common Stock in Q2 2021 and held it in 7 quarters.
Athyrium Capital Management's CareMax, Inc. Class A Common Stock position peaked at $50M in Q2 2021.
86 funds tracked by Wall St. Rank held CareMax, Inc. Class A Common Stock as of Q1 2023.

Based on Athyrium Capital Management's 13F filing for Q1 2023, filed 15 May 2023.